Immunocheckpoint Inhibitor- (Nivolumab-) Associated Hypereosinophilia in Non-Small-Cell Lung Carcinoma

Immunocheckpoint inhibitor (ICI) therapy has provided significant clinical improvements in the treatment of several malignancies. The purpose of this report is to increase awareness of hypereosinophilia associated with checkpoint inhibitors, a topic that has been rarely reported. Hypereosinophilia m...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Navdeep, Lubana, Sandeep Singh, Constantinou, George, Leaf, Andrea N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245658/
https://www.ncbi.nlm.nih.gov/pubmed/32509368
http://dx.doi.org/10.1155/2020/7492634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245658/
https://www.ncbi.nlm.nih.gov/pubmed/32509368
http://dx.doi.org/10.1155/2020/7492634

Ejemplares similares